Samsung gets FDA clearance in US for sleep apnea detection on Galaxy Watch

Planned for Q3 release, the feature is said to detect the signs of sleep apnea by monitoring blood oxygen levels of the user during sleep through supported Galaxy Watches

Sleep apnea feature on Galaxy Watch
Sleep apnea detection on Galaxy Watch
Harsh Shivam New Delhi
2 min read Last Updated : Feb 12 2024 | 10:25 AM IST

Samsung has announced that the sleep apnea feature on the Samsung Health Monitor app has received De Novo authorization from the US Food and Drug Administration (FDA). This feature detects the signs of sleep apnea by monitoring blood oxygen levels of the user during sleep through supported Galaxy Watches. The feature will be available in the US through the Samsung Health Monitor app in the third quarter of 2024.

Last year, Samsung received the approval by South Korea’s Ministry of Food and Drug Safety (MFDS) for the same feature.

The sleep apnea detection feature allows users of age 22 or above to detect the signs of moderate to severe obstructive sleep apnea (OSA) over a two-night monitoring period. Users will be required to track their sleep with the Galaxy Watch twice for more than four hours within a period of ten days. The Galaxy Watch will monitor the blood oxygen level of the user throughout the night to detect any drop in oxygen levels, which is a common symptom of sleep apnea.

Obstructive sleep apnea can cause a person to stop breathing while sleeping that can often result in disruptions in oxygen supply. This results in decreased sleep quality and increased daytime fatigue.

Earlier, Bloomberg’s Mark Gurman reported that Apple is planning to add sleep apnea detection feature alongside blood pressure monitoring on the Apple Watch Series 10, which is expected to launch in September.

Blood Pressure monitoring and electrocardiogram (ECG) monitoring features are already available on the Samsung Galaxy Watch series 4 or later. Last month, Samsung announced that its blood pressure and ECG tracking features have received regulatory clearances and certifications from India’s Central Drugs Standard Control Organization. The features are available in India through the Samsung Health Monitor app. 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :SamsungSamsung Galaxysmartwatcheshealth track devicesTechnology

First Published: Feb 12 2024 | 10:25 AM IST

Next Story